Bausch + Lomb Corp (BLCO)

Bausch + Lomb Corp. is a common equity listing on the NYSE for Bausch + Lomb Corporation, an eye health company focused on products and technologies used in vision care, pharmaceuticals, and surgical eye treatment. The company operates in the United States and a number of international markets, including Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, and Poland. Its Vision Care segment includes contact lenses, lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops. The Pharmaceuticals segment provides proprietary and generic products used in post-operative care and in the treatment of conditions such as glaucoma, eye inflammation, ocular hypertension, dry eye, and retinal diseases. The Surgical segment supplies medical devices, consumables, intraocular lenses, and related technologies for cataract and other eye procedures. Founded in 1853 and headquartered in Vaughan, Canada, the company sells through direct sales forces and independent distributors and operates as a subsidiary of Bausch Health Companies Inc.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.